{
  "trial_id": "NCT01106014",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, PAH subgroup classification, hemodynamic parameters from right heart catheterization, six-minute walk distance (6MWD), BMI, hepatic function (Child-Pugh score), renal function, left ventricular function, lung function (obstructive and restrictive lung disease status), prior use of prostacyclin or its analogs, use of investigational drugs, ability to comply with study requirements, life expectancy, pregnancy status, hypersensitivity to drug excipients.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "PAH etiology",
          "PAH subgroup classification"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "six-minute walk distance (6MWD)"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "PAH medications at baseline",
          "prior use of prostacyclin or its analogs"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Modified NYHA/WHO Functional class (FC)",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "hemodynamic parameters from right heart catheterization",
        "hepatic function (Child-Pugh score)",
        "renal function",
        "left ventricular function",
        "lung function (obstructive and restrictive lung disease status)",
        "use of investigational drugs",
        "ability to comply with study requirements",
        "life expectancy",
        "pregnancy status",
        "hypersensitivity to drug excipients"
      ]
    },
    "processed-gen-response": "Age, gender, PAH subgroup classification, hemodynamic parameters from right heart catheterization, six-minute walk distance (6MWD), BMI, hepatic function (Child-Pugh score), renal function, left ventricular function, lung function (obstructive and restrictive lung disease status), prior use of prostacyclin or its analogs, use of investigational drugs, ability to comply with study requirements, life expectancy, pregnancy status, hypersensitivity to drug excipients."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Six Minute Walk Distance (6MWD), Hemodynamic parameters (e.g., mean pulmonary arterial pressure, pulmonary vascular resistance), PAH etiology (Idiopathic, Heritable, Drug or toxin induced, Associated with Connective tissue disease, Congenital heart disease, HIV infection), Baseline WHO functional class, Concomitant PAH medications, Body Mass Index (BMI),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "PAH etiology",
          "PAH etiology (Idiopathic, Heritable, Drug or toxin induced, Associated with Connective tissue disease, Congenital heart disease, HIV infection)"
        ],
        [
          "Modified NYHA/WHO Functional class (FC)",
          "Baseline WHO functional class"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "Six Minute Walk Distance (6MWD)"
        ]
      ],
      "remaining_reference_features": [
        "PAH medications at baseline",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "Hemodynamic parameters (e.g., mean pulmonary arterial pressure, pulmonary vascular resistance)",
        "Concomitant PAH medications",
        "Body Mass Index (BMI)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Six Minute Walk Distance (6MWD), Hemodynamic parameters (e.g., mean pulmonary arterial pressure, pulmonary vascular resistance), PAH etiology (Idiopathic, Heritable, Drug or toxin induced, Associated with Connective tissue disease, Congenital heart disease, HIV infection), Baseline WHO functional class, Concomitant PAH medications, Body Mass Index (BMI)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Six Minute Walk Distance, World Health Organization Functional Class, Pulmonary Arterial Hypertension Etiology, Pulmonary Arterial Hypertension Duration, Systolic Pulmonary Arterial Pressure, Diastolic Pulmonary Arterial Pressure, Mean Pulmonary Arterial Pressure, Cardiac Output, Pulmonary Vascular Resistance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "PAH etiology",
          "Pulmonary Arterial Hypertension Etiology"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "Six Minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "Modified NYHA/WHO Functional class (FC)",
        "PAH medications at baseline",
        "Time since PAH diagnosis"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "World Health Organization Functional Class",
        "Pulmonary Arterial Hypertension Duration",
        "Systolic Pulmonary Arterial Pressure",
        "Diastolic Pulmonary Arterial Pressure",
        "Mean Pulmonary Arterial Pressure",
        "Cardiac Output",
        "Pulmonary Vascular Resistance"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Six Minute Walk Distance, World Health Organization Functional Class, Pulmonary Arterial Hypertension Etiology, Pulmonary Arterial Hypertension Duration, Systolic Pulmonary Arterial Pressure, Diastolic Pulmonary Arterial Pressure, Mean Pulmonary Arterial Pressure, Cardiac Output, Pulmonary Vascular Resistance."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), six minute walk distance (6MWD), World Health Organization (WHO) functional class, PAH etiology, time since diagnosis, previous PAH therapy, systolic pulmonary artery pressure, mean pulmonary artery pressure, pulmonary vascular resistance, cardiac output, right atrial pressure, left ventricular ejection fraction, creatinine, liver enzymes, hemoglobin, brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "PAH etiology",
          "PAH etiology"
        ],
        [
          "Modified NYHA/WHO Functional class (FC)",
          "World Health Organization (WHO) functional class"
        ],
        [
          "6-minute walk distance (6MWD) at baseline",
          "six minute walk distance (6MWD)"
        ],
        [
          "PAH medications at baseline",
          "previous PAH therapy"
        ],
        [
          "Time since PAH diagnosis",
          "time since diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "systolic pulmonary artery pressure",
        "mean pulmonary artery pressure",
        "pulmonary vascular resistance",
        "cardiac output",
        "right atrial pressure",
        "left ventricular ejection fraction",
        "creatinine",
        "liver enzymes",
        "hemoglobin",
        "brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), six minute walk distance (6MWD), World Health Organization (WHO) functional class, PAH etiology, time since diagnosis, previous PAH therapy, systolic pulmonary artery pressure, mean pulmonary artery pressure, pulmonary vascular resistance, cardiac output, right atrial pressure, left ventricular ejection fraction, creatinine, liver enzymes, hemoglobin, brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP)."
  }
}